ELI LILLY AND COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 918.7 USD | -2.44% |
|
-2.58% | +57.06% |
| 03:53pm | TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850 | MT |
| 03:38pm | Earnings reports take center stage as tech stocks tumble |  |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
2024-08-08
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
941.6
USD
Average target price
901.5
USD
Spread / Average Target
-4.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +57.06% | 848B | |
| +31.64% | 627B | |
| -0.60% | 363B | |
| +15.27% | 318B | |
| +12.26% | 299B | |
| +15.51% | 243B | |
| +16.72% | 225B | |
| +16.01% | 179B | |
| +3.16% | 167B | |
| +2.52% | 125B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850
